Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 1/20 | 0.44 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 2/20 | 0.38 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | TYMP | P19971 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 2/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29326233 | 0.92 | FEN1 (0.45) | FEN1NPEPPSPGRTDP1KDM4E | |
| SCHEMBL27377713 | 0.89 | FEN1 (0.41) | FEN1NPEPPSPGRKDM4EHTT | |
| SCHEMBL29326678 | 0.88 | FASN (0.40) | NPEPPSKDM4EHTTCHEK1GAA | |
| SCHEMBL29326223 | 0.87 | FEN1 (0.58) | FEN1NPEPPSPGRTDP1KDM4E | |
| SCHEMBL29326673 | 0.86 | KDM4E (0.43) | FEN1NPEPPSPGRTDP1KDM4E | |
| SCHEMBL29326335 | 0.85 | NPEPPS (0.43) | FEN1NPEPPSTDP1KDM4EHTT | |
| SCHEMBL29326288 | 0.84 | TDP1 (0.49) | FEN1NPEPPSTDP1KDM4EHTT | |
| SCHEMBL29326300 | 0.83 | KDM4E (0.55) | FEN1NPEPPSPGRTDP1KDM4E | |
| SCHEMBL29326224 | 0.82 | NPEPPS (0.48) | FEN1NPEPPSTDP1KDM4EHTT | |
| SCHEMBL29326295 | 0.81 | KDM4E (0.50) | FEN1NPEPPSPGRTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | GILEAD SCIENCES, INC. | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239807-A1 | SARS-COV2 MAIN PROTEASE INHIBITORS | ACE2, TMPRSS2, ACE | FEN1 1012/4885NPEPPS 168/4885PGR 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.